Dietary Supplements and Hypertension: Potential Benefits and Precautions

Journal of Clinical Hypertension

Volumn 14, Issue 7, 2012, Pages 467-471

  Rasmussen, Carly B ^a   Glisson, James K ^b   Minor, Deborah S ^b  

^a HUNTSVILLE HOSPITAL   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; FISH OIL; UBIDECARENONE;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; ELEUTHEROCOCCUS SENTICOSUS; EPHEDRA; ESSENTIAL HYPERTENSION; FOOD AND DRUG ADMINISTRATION; FOOD SAFETY; GARLIC; GLYCYRRHIZA; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SOUR ORANGE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ASCORBIC ACID; CITRUS; DIETARY SUPPLEMENTS; ELEUTHEROCOCCUS; EPHEDRA; FISH OILS; GARLIC; GLYCYRRHIZA; HUMANS; HYPERTENSION; UBIQUINONE; UNITED STATES;

EID: 84863445058     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00642.x     Document Type: Review

References (33)

1. Glisson JK, Walker LA. How physicians should evaluate dietary supplements. Am J Med. 2010;123:577-582.
2. Yeh GY, Davis RB, Phillips RS. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol. 2006;98:673-680.
3. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. United States Food and Drug Administration Website. Updated May 15, 2009. Accessed August 24, 2011.
4. Overview of Dietary Supplements. United States Food and Drug Administration Website. Updated October 15, 2009. Accessed August 24, 2011.
5. Dietary supplements. United States Food and Drug Administration Website. Updated August 16, 2011. Accessed August 24, 2011.
6. Dietary supplement labeling. United States Food and Drug Administration Website. Updated July 18, 2011 Accessed August 24, 2011.
7. Israelsen L. Spiking: is the end near? Nutraceut World. 2009:57-58. Accessed August 24, 2011.
8. Huang W, Wen K, Hsiao M. Adulteration by synthetic therapeutic substances of traditional Chinese medicine in Taiwan. J Clin Pharmacol. 1997;37:344-350.
9. Gryniewicz C, Reepmeyer J, Kauffman J, Bushe L. Detection of undeclared erectile dysfunction drugs and analogues in dietary supplements by ion mobility spectrometry. J Pharm Biomed Anal. 2009;49:601-606.
10. Wilburn AJ, King DS, Glisson J, et al. The natural treatment of hypertension. J Clin Hypertens. 2004;6:242-248.
11. Singh RB, Niaz MA, Rastogi SS, et al. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens. 1999;13:203-208.
12. Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J. 2001;94:1112-1117.
13. Digiesi V, Cantini F, Oradei A, et al. Coenzyme Q10 in essential hypertension. Mol Aspects Med. 1994;15(suppl 1):S257-S263.
14. Langsjoen P, Willis R, Folkers K. Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med. 1994;15(suppl 1):S265-S272.
15. Prisco D, Paniccia R, Bandinelli B, et al. Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res. 1998;91:105-112.
16. Yosefy C, Viskoper JR, Laszt A, et al. The effects of fish oil on hypertension, plasma lipids and hemostatis in hypertensive, obese, dyslipidemic patients with and without diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 1999;61:83-87.
17. Auer W, Eiber A, Hertkorn E, et al. Hypertension and hyperlipidaemia: garlic helps in mild cases. Br J Clin Pract Suppl. 1990;69:63-66.
18. Vorberg G, Schneider B. Therapy with garlic: results of a placebo-controlled, double-blind study. Br J Clin Pract Suppl. 1990;69:7-11.
19. Reinhart KM, Coleman CI, Teevan C, et al. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother. 2008;42:1766-1771.
20. Silagy CA, Neil HA. A meta-analysis on the effect of garlic on blood pressure [abstract]. J Hypertens. 1994;12:463-468. Accessed August 31, 2011. PMID: 8064171.
21. Simons S, Wollersheim H, Thein T. A systematic review on the influence of trial quality on the effect of garlic on blood pressure. Neth J Med. 2009;67:212-219.
22. Ried K, Frank OR, Stocks NP, et al. Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2008;8:13. Accessed August 24, 2011.
23. Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet. 1999;354:2048-2049.
24. Sato K, Dohi Y, Kojima M, et al. Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension. Arzneimittelforschung. 2006;56:535-540.
25. Shekelle P, Morton S, Maglione M, et al. Ephedra and Ephedrine for Weight Loss and AthleticPerformance Enhancement: Clinical Efficacy and Side Effects. Evidence Report/TechnologyAssessment No. 76 (Prepared by Southern California Evidence-based Practice Center, RAND, under Contract No 290-97-0001, Task Order No. 9). AHRQ Publication No. 03-E022. Rockville, MD: Agency for Healthcare Research and Quality; February 2003.
26. Westfall TC, Westfall DP. Chapter 12. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12 edn. New York: McGraw-Hill; 2011. Accessed August 29, 2011.
27. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-1838.
28. Ephedra: FDA prohibits sales of dietary supplements containing ephedra. National Institutes of Health Website. Accessed August 24, 2011.
29. Bitter orange monograph. In: Jellin M, Gregory PJ, eds. Natural Medicines Comprehensive Database. Accessed August 31, 2011.
30. Bui LT, Nguyen DT, Ambrose PJ. Blood pressure and heart rate effects following a single dose of bitter orange. Ann Pharmacother. 2006;40:53-57.
31. Min B, Cios D, Kluger White CM. Absence of QTc-interval-prolonging or hemodynamic effects of single dose of bitter-orange extract in healthy subjects. Pharmacotherapy. 2005;25:1719-1724.
32. Siberian ginseng monograph. Jellin M, Gregory PJ, eds. Natural Medicines Comprehensive Database. Accessed September 1, 2011.
33. Licorice monograph. Jellin M, Gregory PJ, eds. Natural Medicines Comprehensive Database. Accessed March 28, 2010.